Cooperative Agreement 80NSSC19M0207
- Not listed
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $3.32M research grant by a civilian federal agency through its Shared Services Center to conduct a one-year study examining changes in coronary artery structure and function during spaceflight. This research will establish a critical knowledge base for assessing cardiovascular risk associated with multiyear exploration-class missions, representing an important contribution to understanding the physiological...
- This is a $149,840 grant awarded by the National Aeronautics and Space Administration (NASA) to the University of Texas Southwestern Medical Center (UT Southwestern) to conduct research on sex-specific biomarkers related to space radiation-induced lymphoma. The grant does not have a set-aside designation. As a component of the University of Texas System, UT Southwestern has an extensive history of supporting federal research and clinical initiatives across various agencies, including the...
- This federal contract award to the University of Texas Southwestern Medical Center (UT Southwestern) is a $2,461,498.00 grant for research sponsored by the National Aeronautics and Space Administration (NASA). The purpose is to evaluate the efficacy of the drug GC4419, a superoxide dismutase mimetic, in mitigating space radiation-induced carcinogenesis, with a focus on lung cancer. This research aims to identify effective biological countermeasures that can increase the amount of time astronauts...
- This is a $1,199,998.00 grant award from the National Aeronautics and Space Administration (NASA) to the University of Texas Southwestern Medical Center (UT Southwestern) for research evaluating the cellular and molecular responses of lung and liver cells derived from induced pluripotent stem cells (iPSCs) with varying intrinsic radiosensitivity to space radiation. The award is a research grant with no set-aside designation, with a performance period through December 31, 2025. UT Southwestern is...
- This is a $2,478,052.00 grant award from the National Aeronautics and Space Administration (NASA) to the University of Texas Southwestern Medical Center (UT Southwestern) in Dallas, Texas. The grant is part of NASA's "MOUSE MODELS OF CANCER RISK AND PREVENTION FROM SPACE RADIATION" program and supports research on the molecular effects of low-dose space radiation exposure. The objective is to use mouse models to understand how different types and doses of radiation impact the...
- This is a $259,760.00 research grant awarded by the National Aeronautics and Space Administration (NASA) to the University of Texas Southwestern Medical Center (UT Southwestern), a component of the University of Texas System. The grant is for the "Venous Congestion Countermeasure Study", a directed proposal from NASA's Human Research Program, which involves two external co-investigators. The study is expected to run from October 2018 through September 2020. No set-aside designation...
- This federal grant award to The University of Texas Southwestern Medical Center (UT Southwestern) supports a research project focused on understanding the mechanisms of particle radiation-induced carcinogenesis, specifically related to the development of glioblastoma (GBM) brain tumors. The $942,142.04 grant, awarded by the National Aeronautics and Space Administration (NASA), aims to utilize validated mouse models to analyze the effects of different types of charged particles, such as those...
- This federal contract award, identified as NNX15AP25G, was granted to The University of Texas Southwestern Medical Center (UT Southwestern) to analyze data from the Integrated Cardiovascular (ICV) experiment conducted on the International Space Station. The focus of this $89,853.72 grant is to assess the risk of atrial fibrillation (AFib), a common cardiac arrhythmia, in astronauts. UT Southwestern, a non-profit academic medical center, will leverage the extensive cardiac data collected...
- This federal contract award, with ID 80NSSC18K1639, was granted by the Shared Services Center of the National Aeronautics and Space Administration (NASA) to the University of Texas MD Anderson Cancer Center, a child entity of the University of Texas System. The $1,030,692 grant aims to acquire data on cardiovascular impairments and associated biomarkers observed in patients undergoing cardiac exposure to ionizing radiation, with a focus on non-invasive imaging modalities. The research is...
- This federal contract award was made by the National Heart Lung and Blood Institute, a civilian agency within the National Institutes of Health, to the University of Texas Southwestern Medical Center (UT Southwestern). The $3,690,384.38 definitive contract covers biomedical research services with a period of performance ending on July 10, 2015. There was no set-aside designation for this award. UT Southwestern is a prime contractor and subcontractor with extensive experience providing...
The National Aeronautics and Space Administration (NASA) awarded a $318,782.00 cooperative agreement to the University of Texas Southwestern Medical Center (UT Southwestern) to develop a series of 12 short-term risk models for cardiovascular disease (CVD) assessment to apply the effects of radiation exposure. This project is not associated with any set-aside designation. UT Southwestern, an academic medical center in Dallas, Texas, is a component of the University of Texas System. The university has extensive experience providing medical research, clinical care, and other solutions to federal agencies, including the Department of Veterans Affairs and Defense Health Agency. UT Southwestern has participated in numerous federal grants and cooperative agreements across the National Institutes of Health, supporting research in areas such as cardiovascular disease, cancer, and neurological disorders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Other Administrative Action | $0 | 9/29/21 | |
| Not listed | $0 | 9/29/21 | ||
| P00004 | Funding Only Action | $88.9k | 3/24/21 | |
| Not listed | $88.9k | 3/24/21 | ||
| P00003 | Funding Only Action | $72.0k | 9/24/20 |